News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
333,947 Results
Type
Article (20211)
Company Profile (51)
Press Release (313681)
Multimedia
Podcasts (33)
Webinars (11)
Section
Business (82053)
Career Advice (888)
Deals (13130)
Drug Delivery (49)
Drug Development (61622)
Employer Resources (62)
FDA (10890)
Job Trends (7744)
News (170489)
Policy (19435)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
Academia (1446)
Academic (1)
Accelerated approval (21)
Adcomms (24)
Allergies (114)
Alliances (23036)
ALS (125)
Alzheimer's disease (1148)
Antibody-drug conjugate (ADC) (220)
Approvals (11178)
Artificial intelligence (296)
Autoimmune disease (108)
Automation (31)
Bankruptcy (99)
Best Places to Work (6476)
BIOSECURE Act (6)
Biosimilars (115)
Biotechnology (29)
Bladder cancer (133)
Brain cancer (36)
Breast cancer (451)
Cancer (3540)
Cardiovascular disease (295)
Career advice (747)
Career pathing (24)
CAR-T (212)
CDC (32)
Celiac Disease (2)
Cell therapy (499)
Cervical cancer (27)
Clinical research (55869)
Collaboration (911)
Company closure (1)
Compensation (157)
Complete response letters (50)
COVID-19 (1849)
CRISPR (61)
C-suite (328)
Cystic fibrosis (98)
Data (5092)
Denatured (9)
Depression (99)
Diabetes (344)
Diagnostics (4506)
Digital health (22)
Diversity (1)
Diversity, equity & inclusion (12)
Drug discovery (153)
Drug pricing (46)
Drug shortages (13)
Duchenne muscular dystrophy (192)
Earnings (34916)
Editorial (22)
Employer branding (9)
Employer resources (54)
Events (42058)
Executive appointments (431)
FDA (13251)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (8)
Frontotemporal dementia (14)
Funding (707)
Gene editing (123)
Generative AI (22)
Gene therapy (415)
GLP-1 (673)
Government (3259)
Grass and pollen (7)
Guidances (227)
Healthcare (8529)
HIV (43)
Huntington's disease (28)
IgA nephropathy (74)
Immunology and inflammation (150)
Immuno-oncology (34)
Indications (89)
Infectious disease (2057)
Inflammatory bowel disease (126)
Influenza (99)
Intellectual property (128)
Interviews (127)
IPO (5783)
IRA (8)
Job creations (1556)
Job search strategy (659)
JPM (21)
Kidney cancer (13)
Labor market (46)
Layoffs (203)
Leadership (22)
Legal (2867)
Liver cancer (69)
Longevity (8)
Lung cancer (524)
Lymphoma (334)
Machine learning (25)
Management (19)
Manufacturing (396)
MASH (109)
Medical device (5964)
Medtech (5981)
Mergers & acquisitions (7839)
Metabolic disorders (844)
Multiple sclerosis (128)
NASH (12)
Neurodegenerative disease (206)
Neuropsychiatric disorders (57)
Neuroscience (2038)
Neurotech (1)
NextGen: Class of 2026 (2588)
Non-profit (1708)
Now hiring (34)
Obesity (374)
Opinion (160)
Ovarian cancer (128)
Pain (144)
Pancreatic cancer (149)
Parkinson's disease (220)
Partnered (21)
Patents (225)
Patient recruitment (440)
Peanut (50)
People (22172)
Pharmaceutical (13)
Pharmacy benefit managers (9)
Phase 1 (17760)
Phase 2 (24294)
Phase 3 (18630)
Pipeline (3828)
Policy (93)
Postmarket research (1771)
Preclinical (4701)
Press Release (38)
Prostate cancer (175)
Psychedelics (30)
Radiopharmaceuticals (147)
Rare diseases (570)
Real estate (3289)
Recruiting (23)
Regulatory (16686)
Reports (26)
Research institute (1365)
Resumes & cover letters (131)
Rett syndrome (27)
RNA editing (5)
RSV (57)
Schizophrenia (118)
Series A (109)
Series B (87)
Service/supplier (2)
Sickle cell disease (55)
Special edition (11)
Spinal muscular atrophy (132)
Sponsored (23)
Startups (1465)
State (1)
Stomach cancer (15)
Supply chain (55)
Tariffs (16)
The Weekly (23)
Vaccines (655)
Venture capital (33)
Weight loss (250)
Women's health (55)
Worklife (6)
Date
Today (46)
Last 7 days (291)
Last 30 days (1155)
Last 365 days (17570)
2026 (1620)
2025 (17726)
2024 (19894)
2023 (22596)
2022 (27941)
2021 (29536)
2020 (28860)
2019 (22024)
2018 (16594)
2017 (16612)
2016 (15332)
2015 (17169)
2014 (12648)
2013 (10377)
2012 (10932)
2011 (11534)
2010 (10027)
Location
Africa (339)
Alabama (66)
Alaska (2)
Arizona (110)
Arkansas (8)
Asia (21594)
Australia (3545)
California (6171)
Canada (1700)
China (777)
Colorado (259)
Connecticut (295)
Delaware (211)
Europe (46162)
Florida (848)
Georgia (196)
Hawaii (2)
Idaho (25)
Illinois (416)
India (40)
Indiana (272)
Iowa (14)
Japan (311)
Kansas (74)
Kentucky (27)
Louisiana (17)
Maine (50)
Maryland (885)
Massachusetts (4304)
Michigan (209)
Minnesota (272)
Mississippi (3)
Missouri (94)
Montana (27)
Nebraska (20)
Nevada (63)
New Hampshire (34)
New Jersey (1984)
New Mexico (16)
New York (1793)
North Carolina (798)
North Dakota (4)
Northern California (2992)
Ohio (188)
Oklahoma (12)
Oregon (25)
Pennsylvania (1289)
Puerto Rico (9)
Rhode Island (20)
South America (527)
South Carolina (29)
Southern California (2451)
Tennessee (97)
Texas (1011)
United States (22414)
Utah (194)
Virginia (164)
Washington D.C. (38)
Washington State (495)
West Virginia (2)
Wisconsin (52)
Wyoming (1)
333,947 Results for "cp lab safety".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ASH 2025 | Ascentage Pharma Presents Four-Year Follow-Up Data from Registrational Phase II Study of Olverembatinib, Reaffirming Differentiated Long-Term Efficacy and Safety in TKI-Resistant/Intolerant CML-CP
December 9, 2025
·
12 min read
Press Releases
ASH 2025 | Updated Data for Ascentage Pharma‘s Olverembatinib in Second-Line CML-CP Showing Encouraging Potential for Early-Line Treatment
December 9, 2025
·
11 min read
Press Releases
EVQLV Launches Abtique, the First Marketplace for AI-Designed Molecules Validated in Independent Labs
New “click-to-sequence” platform lets researchers buy AI-designed antibody sequences online, using an AI system that learns from real lab results
November 20, 2025
·
1 min read
Press Releases
Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium
February 8, 2026
·
2 min read
Press Releases
Slope and CellCarta Expand Collaboration with Lab Kit Inventory Portal Agreement
February 3, 2026
·
3 min read
Press Releases
LifeCanvas to advance spatial profiling of human tumors with translational cancer lab
February 3, 2026
·
2 min read
Press Releases
Tasca Therapeutics Doses First Patient in Phase 1/2 Dose Escalation and Expansion Trial Evaluating CP-383 in Advanced Solid Tumors
September 17, 2025
·
2 min read
Press Releases
Gaelic Labs’ acquisition of Athlone boosts Gaelic’s leadership in the Beta Lactam industry
Gaelic Laboratories, a world-class manufacturer of Beta-Lactam (penicillin) products, today announces its acquisition of Athlone Laboratories, a leading developer and manufacturer of oral dose Beta-Lactams, in a step that strengthens Gaelic’s market position, enhances manufacturing capabilities, and leverages supply chain efficiencies.
December 12, 2025
·
1 min read
Press Releases
Sky Labs Signs Exclusive Distribution Agreement with Otsuka Pharmaceutical for ‘CART BP pro’ in Japan
February 6, 2026
·
4 min read
Press Releases
Unchained Labs Cracks the Code on ADC Characterization
January 6, 2026
·
1 min read
1 of 33,395
Next
